Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Antineoplastics

Nausea, poor appetite and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat He L, et al. Complete remission in a pretreated, microsatellite-stable, KRAS-mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy: a case report and literature review. [Review] Frontiers in Immunology 15: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fimmu.2024.1354613 He L, et al. Complete remission in a pretreated, microsatellite-stable, KRAS-mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy: a case report and literature review. [Review] Frontiers in Immunology 15: Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​3389/​fimmu.​2024.​1354613
Metadaten
Titel
Antineoplastics
Nausea, poor appetite and lack of efficacy
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57969-7

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Tozinameran

Case report

Antibacterials

Case report

Antineoplastics

Case report

Antineoplastics